NCT02716285View on ClinicalTrials.gov

Peppermint Oil for the Treatment of Irritable Bowel Syndrome: Optimizing Therapeutic Strategies Using Targeted Delivery

PHASE3CompletedINTERVENTIONAL
Enrollment

190

Participants

Timeline

Start Date

August 17, 2016

Primary Completion Date

May 1, 2018

Study Completion Date

October 1, 2018

Conditions
Irritable Bowel SyndromeAbdominal PainColonic Diseases, Functional
Interventions
DRUG

Ileocolonic release peppermint oil

Peppermint oil, menthae piperitae aetheroleum

DRUG

Placebo

Placebo capsule, containing microcrystalline cellulose

DRUG

Small intestinal release peppermint oil

Peppermint oil, menthae piperitae aetheroleum

Trial Locations (4)

6716 RP

Gelderse Vallei Hospital, Ede

8934 AD

Medical Center Leeuwarden, Leeuwarden

2334 CK

Alrijne Hospital, Leiden

6229 ER

Maastricht University Medical Center, Maastricht

All Listed Sponsors
collaborator

ZonMw: The Netherlands Organisation for Health Research and Development

OTHER

lead

Maastricht University Medical Center

OTHER

NCT02716285 - Peppermint Oil for the Treatment of Irritable Bowel Syndrome: Optimizing Therapeutic Strategies Using Targeted Delivery | Biotech Hunter | Biotech Hunter